← All companies

NXTC

NextCure, Inc.

NXTC Nasdaq Pharmaceutical Preparations EDGAR ↗

$4.40

-0.63 -12.52%

Key statistics

from XBRL data in SEC filings

Market cap

$15.9M

Revenue (TTM)

$27.4M

Net income (TTM)

-$54.7M

EPS (TTM)

$-16.82

P/E ratio

—

Dividend yield

—

Free cash flow

-$50.1M

Cash

$15.2M

Total assets

$38.0M

Gross margin

—

52-week range

$1.55 – $15.74

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Exit or disposal costs; Change in control; Director or officer change; Regulation FD disclosure; Other events Jul 14, 2026 8-K Director or officer change; Shareholder vote results Jun 25, 2026 8-K Regulation FD disclosure; Other events Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 23, 2026 8-K Other events Dec 19, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Director or officer change Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Modified rights of security holders; Amended charter or bylaws Jul 14, 2025 8-K Other events Jul 10, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jun 16, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 8-K Regulation FD disclosure Apr 10, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Delisting notice or listing-rule failure Feb 3, 2025 8-K Other events Jan 10, 2025 8-K Other events Dec 10, 2024 8-K Regulation FD disclosure Dec 5, 2024 8-K Regulation FD disclosure Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Shareholder vote results Jun 21, 2024 8-K Director or officer change Jun 18, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 21, 2024 8-K Regulation FD disclosure Dec 14, 2023